-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2024-515194-10-00
5
Metastatic hormone-sensitive prostate cancer with high tumor load
-
2025-524289-56-00
6
Asthma
-
2024-511166-36-00
5
2025-06-13
Moderate to Severe Plaque Psoriasis
-
2024-516360-29-00
4
2025-04-25
Complicated Urinary Tract Infection (cUTI),
Acute Pyelonephritis (AP)
-
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2025-523975-48-00
5
2026-05-08
Obesity
-
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
-
2025-523974-18-00
5
2026-04-30
Obesity
-
2025-523156-31-00
4
2026-03-17
Respiratory Syncytial Virus
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2024-518438-94-00
4
2025-10-24
Heart failure
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-513171-41-00
5
2025-09-11
Vitiligo
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2023-503634-50-01
5
2025-07-22
Anemia in patients with chronic kidney disease on dialysis
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-515868-31-00
5
2025-06-10
Varicella
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-512496-12-00
5
2025-04-01
Moderate to Severe Plaque Psoriasis
-
2024-511652-40-00
5
2025-02-05
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2023-508760-29-00
5
2024-10-21
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)